Michael Connelly

Michael Connelly, M.D. is an accomplished medical professional with extensive experience in clinical research and pharmacovigilance. Currently serving as Medical Director and Senior Patient Safety Physician at AstraZeneca, Michael leads a team focused on the safety evaluation of clinical studies. Michael also holds the role of Drug Safety Officer at InSitu Biologics, Inc., where responsibilities include providing expertise in pharmacovigilance and risk management, as well as engaging with external stakeholders. Prior experience includes managing clinical trial sites at Sollis Therapeutics and conducting research at UTHealth. Michael earned a Doctor of Medicine degree from The University of Texas Health Science Center at Houston and a Bachelor of Science in Biology from Southern Methodist University.